ASCACID 10% 100/1000 ml

DECLARATION OF ACTIVE SUBSTANCES AND OTHER INGREDIENTS

100 ml suspension contains:

Albendazole (methyl-5N-propylthio-2-benzimidazole carbamate) 10 g
Excipients: monopropylene glycol, sodium carboxymethylcellulose, sodium benzoate, demineralised water

INDICATIONS
The product is indicated in cattle for the treatment of gastrointestinal and pulmonary nematodes (Ostertagia spp., Nematodirus spp., Haemonchus spp., Trichostongylus spp., Cooperia spp., Dictyocaulus spp., Bunostomum spp., Oesophagostomum spp.), trematodes (Fasciola spp.) and cestodes (Moniesia spp.).

CONTRAINDICATIONS
Due to the potential teratogenic and embryotoxic effect, it should not be administered during the first 45 days of gestation.

ADVERSE REACTIONS
The product is well tolerated in therapeutic doses. If you notice severe effects or other effects not mentioned in this leaflet, notify your veterinarian urgently.

SPECIES DYE
Bovine.

DOSAGE FOR EACH SPECIES, ROUTES AND MODE OF ADMINISTRATION
ASCACID 10% is administered orally by syringe or other graduated device for administering oral suspensions to animals in a single dose of 10 mg albendazole/kg body weight (10 ml Ascacid 10%/100 kg body weight).
In case of re-infestation the treatment is repeated after 3 months.
To ensure correct administration of the therapeutic dose, the body weight of the animal should be determined as accurately as possible.
If several animals are treated at the same time, they should be grouped according to their weight and the dose adjusted accordingly to avoid under- or overdosage.

RECOMMENDATIONS FOR CORRECT ADMINISTRATION
Shake the bottle before use.

WAITING TIME
Meat and organs: 28 days

Milk: 3 days

STORAGE PRECAUTIONS
The product should be stored in a dry, dark place, below 25°C, protected from frost.

SPECIAL WARNINGS
Special warnings for each target species:
The following practices increase the risk of resistance development and consequently may result in ineffective anthelmintic therapy:
Repeated and too frequent use of anthelmintics of the same class over an extended period of time.
Under-dosing, which can be caused by underestimating the animal's body weight or incorrect product administration.
Suspected clinical cases of anthelmintic resistance should be investigated using paraclinical tests, e.g. total egg count reduction test. If tests indicate resistance to a particular class of anthelmintic, an anthelmintic with a different mode of action should be used by changing the class.
Resistance to albendazole has been reported on Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp. Therefore the use of this product should be supported by local (regional, farm level) epidemiological information on the susceptibility of Fasciola hepatica, Trichostrongylus spp, Haemonchus spp and Oesophagostomum spp and accompanied by recommendations on how to limit the selection of resistance to albendazole.
Use during gestation, lactation
Due to the potential teratogenic and embryotoxic effect it is not to be used during the first month of gestation.
Interactions with other medicinal products or other forms of interaction
Do not associate with cimetidine and praziquantel which decrease the absorption of albendazole by changing the Ph in the rumen.
Overdose (symptoms, emergency procedures, antidotes), as appropriate
Exceeding the dose up to 20 times does not cause adverse reactions.

SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED PRODUCT OR WASTE, AS APPROPRIATE.
Treated animals should be kept in isolation and the droppings should not be used to fertilise the soil.
Any unused veterinary medicinal product or waste from the use of such products must be disposed of in accordance with local requirements.